logo-loader

Sales of Rex Bionics’ robots gaining traction

Published: 13:16 27 Nov 2015 GMT

Crispin Simon, chief executive of Rex Bionics (LON:RXB), says sales of the company’s robotic exoskeleton are gaining traction including interest from leading clinics in the United States.

He was speaking after clinical trial data showed 19 out of 20 volunteers successfully exercised in the robotic legs and “would like to use the Rex on a weekly basis” as part of their physiotherapy regime.

The medical tech firm is selling aggressively with three confirmed sales of its robots in the first half with more sales anticipated in the second half.  Simon says the sales pipeline is growing and “eventually we’ll reach a tipping point and we would expect every hospital to have one.”

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

1 hour, 10 minutes ago